Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology Sarah E. GibsonStefan DojcinovElena Sabattini REVIEW AND PERSPECTIVES Open access 02 August 2023 Pages: 733 - 749
Morphologic spectrum of the epithelial tumors of the male and female urethra Alessia CimadamoreAntonio Lopez-BeltranRodolfo Montironi Review and Perspectives Open access 26 May 2023 Pages: 751 - 764
Stromal grading predicts pathologic complete response and prognosis in triple-negative breast cancer Sean M. HackingYihong Wang ORIGINAL ARTICLE 15 February 2023 Pages: 765 - 774
Bringing pathology to nanomedicine: a comparison of in vivo toxicity of polymeric nanoparticle carriers with and without chitosan coating Christos PouliosVarvara KaragkiozakiStergios Logothetidis Original Article Open access 04 July 2023 Pages: 775 - 786
Validation of Modaplex POLE mutation assay in endometrial carcinoma Eduard DorcaAna VelascoXavier Matias-Guiu ORIGINAL ARTICLE Open access 24 October 2023 Pages: 787 - 794
MDM2 amplification is rare in gastric cancer Samir AbdullazadeHans-Michael BehrensChristoph Röcken Original Article Open access 11 October 2023 Pages: 795 - 807
Clinicopathological differences in focal segmental glomerulosclerosis depending on the accompanying pathophysiological conditions in renal allografts Sekiko TanedaKazuho HondaYoji Nagashima ORIGINAL ARTICLE Open access 18 November 2023 Pages: 809 - 819
mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy Anna CaliòStefano MarlettaGuido Martignoni ORIGINAL ARTICLE Open access 08 November 2023 Pages: 821 - 833
Targeted NGS on sequential bone marrow biopsies aids in the evaluation of cytopenias and monocytosis and documents clonal evolution—a proof of principle study Dominik NannAchim RauFalko Fend Original Article Open access 23 August 2023 Pages: 835 - 845
Refining the application of PRAME—a useful marker in high CSD and acral melanoma subtypes Craig WakefieldLaura O’KeefeCynthia C. B. B. Heffron ORIGINAL ARTICLE 19 September 2023 Pages: 847 - 854
Discordance in PD-L1 expression using 22C3 and SP142 assays between primary and metastatic triple-negative breast cancer Jun MiyakoshiShu YazakiKan Yonemori ORIGINAL ARTICLE 05 September 2023 Pages: 855 - 863
Cause of death and the autopsy rate in an elderly population Bartholomeus G. H. LattenBela KubatLeo J. Schouten ORIGINAL ARTICLE Open access 03 June 2023 Pages: 865 - 872
Peritoneal papillary mesothelioma in situ: BAP1 mutation with indolent behavior for 15 years Nikola VitlarovE. BurtscherF. A. Offner BRIEF REPORT 10 July 2023 Pages: 873 - 878
High-grade serous ovarian carcinoma with a sertoliform pattern associated with BRCA mutation: a clinicopathological and molecular analysis Antonio TravaglinoAngela SantoroGian Franco Zannoni BRIEF REPORT 11 May 2023 Pages: 879 - 883
H3K27me3 deficiency in dedifferentiated carcinoma and carcinosarcoma of the endometrium Atsushi KiharaYusuke AmanoToshiro Niki Brief Report 28 September 2023 Pages: 885 - 890
KMT2A-rearranged sarcoma with unusual fusion gene CBX6::KMT2A::PYGO1 Harumi NakamuraYoji KukitaToshinari Yagi Brief Report 15 September 2023 Pages: 891 - 897
Pseudoendocrine sarcoma: clinicopathologic, molecular, and epigenetic features of one case M. Adelita VizcainoAndrew L. FolpeCaterina Giannini Brief Report 13 November 2023 Pages: 899 - 904